Patient Portal Market worth 2.74 Billion USD by 2020

The report “Patient Portal Market - by Type (Standalone, and Integrated portal), by Delivery Mode (Web-Based, and Cloud- Based), & by End Users (Providers, Payers, Pharmacies, and Others) - Analysis & Global Forecast to 2020”, analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape and geographical markets. This report studies the global patient portal market for the forecast period of 2015 to 2020. This market is expected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1%.

               

Browse 80 tables and 32 figures spread through 161 Pages and in-depth TOC on "Patient Portal Market - by Type (Standalone, and Integrated portal), by Delivery Mode (Web-Based, and Cloud- Based), & by End Users (Providers, Payers, Pharmacies, and Others) - Analysis & Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/patient-portal-market-49094801.html
Early buyers will receive 10% customization on reports.

The global patient portal market is segmented on the basis of type, delivery mode, end user, and region.

By type, the patient portal market is categorized into standalone and integrated patient portals. The integrated portals are estimated to account for the largest share of the global patient portal market, by type, in 2015. This large share can be attributed to the fact that most of the integrated portals are provided by the same vendor as an electronic health record (EHR) system. These solutions allow a user to complete multiple business functions from within the same interface. As they provide a one-stop solution, they are cheaper, favored, and therefore high in demand.

On the basis of delivery mode, the market is segmented into web-based and cloud-based modes. In 2015, web-based mode of delivery is expected to command the largest share of the global patient portal market. However, the cloud-based mode of delivery is expected to grow at a higher CAGR due to its advantages—cloud-based services can help healthcare organizations share and integrate information from disparate locations or systems in real time and generate a database registry.

The patient portal market has been further segmented by end users into providers, payers, pharmacies, and others. Providers include hospitals, ambulatory care centers, home healthcare agencies, nursing homes, diagnostic & imaging centers, and physicians. Other end users include employer groups and government entities. In 2015, the providers’ segment is expected to command the largest share of the global patient portal market, by end user. Rising mandates for incentive programs for providers; government initiatives to improve the quality of care delivered to patients and curtail the soaring cost of healthcare among providers; and the growing need to improve the affordability and accessibility of healthcare services are some factors propelling the use of patient portal solutions among providers.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America is poised to account for the largest share of the patient portal market, followed by Europe and Asia-Pacific. However, the European region is slated to grow at the highest CAGR during the forecast period. The large share of the North American patient portal market can primarily be attributed to the federal mandates in the U.S., rising number of accountable care organizations in the U.S., rising aging population in the U.S., Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=49094801

Federal mandates like the Meaningful Use incentives, growing patient-centric approach in healthcare delivery, increasing EHR adoption, and growing popularity of patient portals among the elderly are some factors expected to drive the growth of the global patient portal market in the coming years.

Allscripts Healthcare Solutions, Inc. (U.S.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), CureMD (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Greenway Health, LLC (U.S.), Medfusion (U.S.), Epic Corporation Inc. (U.S.), GE Healthcare (U.K.), and Intelichart (U.S.) are some of the key players in the patient portal market worldwide.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Clinical Trial Supplies Market worth 1.2 Billion USD by 2020

The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

             

Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
Early buyers will receive 10% customization on reports.

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.

The report segments this market based on products and services, phases, therapeutic areas, and regions. Among the various products and services, the logistics and distribution services segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the factors such as globalization of clinical trials and increasing outsourcing of services.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are the factors propelling the growth of this market.

Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

Download PDF Brochure: http://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html

Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), and Thermo Fisher Scientific, Inc. (U.S.)

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Neuromodulation Market worth $6.20 Billion by 2020

The report “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020” analyzes and studies the major market drivers, restraints, and opportunities.

Browse 84 market data tables and 32 figures spread through 182 pages and in-depth TOC on “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
Early buyers will receive 10% customization on reports.

This report studies the global neuromodulation market from 2015 to 2020. The global neuromodulation market is estimated at $3.65 Billion in 2015, and is projected to reach $6.20 Billion by 2020, at a CAGR of 11.2% during the forecast period. The global neuromodulation market is segmented on the basis of technology, application, and region.

Based on technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=921

Based on application, the neuromodulation market is segmented into technology-wise applications, such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinsons disease, tremor, depression, others); sacral nerve stimulation (urine incontinence, fecal incontinence); vagus nerve stimulation (epilepsy, others); gastric electrical stimulation (gastro paresis, obesity); transcutaneous electrical nerve stimulation (treatment resistant depression, others); and transcranial magnetic stimulation (depression, migraine headaches).

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). The rest of the world region comprises Latin America, the Middle East, and Africa. North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015.

Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications are driving the growth of this market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are hindering its market growth.

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

Walking Assist Devices Market worth 6.57 Billion USD by 2020

The report "Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) - Global Forecast to 2020", The global Walking Assist Devices Market report defines and segments the walking assist devices market globally with analysis and forecast of revenue. The global walking assist devices market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

Browse 108 market data Tables and 112 Figures spread through 168 Pages and in-depth TOC on "Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) - Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/walking-assist-devices-market-24035174.html
Early buyers will receive 10% customization on reports.

The global walking assist devices market growth is attributed to the rising aging population, increasing incidences of debilitating neurological diseases & injuries, and technological advancements & product leasing that have led to the increase in usage of walking assist devices.

The rise in elderly population and increasing technological advancements are some factors that have led to the growth of the global walking assist devices market. According to the World Health Organization (WHO), the global population in the age group of 60 years and above is expected to grow from 841 Million in 2013 to more than 2 Billion by 2050, which is more than double the population as of 2013.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=24035174

This market is segmented and forecast on the basis of product, and geography. The product comprises of gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, Asia-pacific and Rest of the World (RoW). These major geographies are further sub-segmented into major countries. The global walking assist devices market was dominated by North America in 2014.

The market in North America is growing due to rise in aging population and favorable reimbursement. The European market is growing due to the technological advancements and government support and along with increase in the spending capacity population.

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide walking assist devices as a product.

The research study is aimed at identifying emerging trends and opportunities in the global walking assist devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global walking assist devices market, on the basis of product, and region.

Pain Management Devices Market by Device Type, Application & Mode of Purchase - 2021

The report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

     

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" 
http://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

Professional Dental Care Market worth 961.0 Million USD by 2021

The report "Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, challenges, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 172 market data tables and 26 figures spread through 178 pages and in-depth TOC on “Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/professional-dental-care-market-210346692.html
Early buyers will receive 10% customization on reports.

The professional dental care market witnessed moderate growth during the last decade and is expected to grow at a CAGR of 4.5% between 2016 and 2021 to reach USD 961.0 Million by 2021. The growth in this market is majorly attributed to factors such as increasing small/private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing awareness about dental hygiene, and economic gain for dental practitioners.

The global professional dental care market is segmented based on product type and geography. In recent years, the dental industry is gaining more importance due to increased demand of having specialized products, treatments and procedures to treat dental diseases. In 2015, toothpastes segment accounted for the largest share of global professional dental care market. The toothbrushes segment is expected to witness the fastest growth over the next five years. The high growth of this segment can be attributed to higher utilization of the manual toothbrushes by end-users and recent technological advancements in the electric toothbrushes.

Europe is the largest regional segment for professional dental care market owing to the well-established dental market. The largest share of this regional segment is driven by the increase in the aging population, rising demand for the advance oral care products, increase in governmental expenditure on oral healthcare across Europe, and rising awareness about dental hygiene. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising geriatric population, rising awareness about dental hygiene, and increase medical tourism in countries such as India and China. The market players, namely, Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), GlaxoSmithKline plc (U.K.), and Unilever plc (U.K.) held the major share of the professional dental care market and will continue to dominate the market between 2016 and 2021.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=210346692

Some of the other players operating in this market are Johnson and Johnson (U.S.), Dr. Fresh, LLC (U.S.), Young Innovation Inc. (U.S.), Ultradent Products, Inc. (U.S.), GC Corporation (Japan), Henkel AG & Company, KGaA (Germany), 3M Company (U.S.), Koninklijke Philips N.V. (Netherlands), and Sunstar (Japan).

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Endodontics Market worth 1.61 Billion USD by 2022

The report "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022", The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes.

Browse 194 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on "Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/endodontics-market-222473576.html
Early buyers will receive 10% customization on reports.

The consumables segment to dominate the endodontics market during the forecast period

Based on product, the endodontics market is segmented into consumables and instruments. The consumables segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the growing number of root canal procedures globally.

Dental clinics to witness the highest growth rate during the forecast period

On the basis of end users, the endodontics market is segmented into dental clinics, dental hospitals, and dental academic & research institutes. The dental clinics segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.

Europe dominated the market in 2016

Europe accounted for the largest share of the endodontics market in 2016, followed by North America. The large share of this region is attributed to the increasing prevalence of dental diseases, growth in the aging population, increasing demand for advanced dental procedures, growing dental tourism in some European countries, increasing number of dental clinics and hospitals, and increasing dental care expenditure in countries such as Germany and the UK.

The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Dental Digital X-ray Market by Product, Application & End User - 2020

The global dental digital X-ray market is projected to reach USD 3,290.6 Million by 2020 from USD 2,154.0 Million in 2015, at a CAGR of 8.8%. Factors such as technological advancements, growing geriatric population, ability of digital systems to reduce diagnosis time and improve image quality, growing adoption of CBCT systems, increase in dental disorders, and growing demand for cosmetic dentistry are the driving the digital X-ray market. On the other hand, factors such as high cost of dental digital X-rays and lack of reimbursements for dental care are restraining the growth of the digital X-ray imaging market.

http://www.marketsandmarkets.com/Market-Reports/dental-digital-x-ray-market-102002511.html

Based on type, the dental digital X-ray market is segmented into intraoral X-ray systems, extraoral X-ray systems, and hybrid X-ray systems. Hybrid X-ray systems are expected to grow at the highest CAGR during the forecast period, owing to the advantages of hybrid systems such as minimum exposure to radiation, lower price of these systems as compared to high-end digital panoramic/cephalometric units, and technological advancements and rapid digitization in dentistry.

The intraoral X-ray systems market is segmented into PSP systems and digital sensors. The digital sensors segment accounted for the largest market share in 2015 and will continue to dominate the market in the forecast period. The large share of this segment can be attributed to the significant reduction in operating time and excellent-quality images obtained from these sensors as compared to PSP systems.

The extraoral X-ray systems market is categorized into panoramic/cephalometric systems and CBCT systems. The CBCT systems segment is expected to grow at the highest CAGR during the forecast period. High growth in this segment is primarily driven by the growing dental implants market and increase in the number of vendors offering CBCT units in the dental market.

Based on application, the dental digital X-ray market is segmented into diagnostic, therapeutic, cosmetic, and forensic applications. In 2015, the diagnostic applications segment accounted for the largest share of the global dental digital X-ray market. The rising prevalence of dental disorders, rise in geriatric population, increasing oral health awareness, and rising disposable incomes in developing economies such as China and India are likely to drive the demand for digital dental diagnosis.

Based on end user, the dental digital X-ray market is segmented into dental hospitals and clinics, dental academic and research institutes, and forensic laboratories. The dental hospitals and clinics segment accounted for the largest share of the market; this segment is also projected to witness the highest growth rate CAGR during the forecast period. The increasing number of dental clinics and hospitals and their rapid adoption of digital dental imaging systems is contributing to the growth of this end-user segment.

The global dental digital X-ray market is dominated by North America, followed by Europe. However, the market in Asia is expected to register the highest CAGR during the forecast period. Growth in the Asian market is driven by the rising geriatric population, focus of emerging and leading market players to expand their presence in developing Asian markets, rise in disposable incomes, less stringent regulatory guidelines, improving healthcare infrastructure, and growth in medical tourism in this region.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=102002511

Key players in dental digital X-ray market include Danaher Corporation (U.S.), Carestream Health, Inc. (U.S.), Sirona Dental Systems, Inc. (U.S.), Planmeca Oy (Finland), Vatech Co. Ltd. (Republic of Korea), LED Medical Diagnostic, Inc. (Canada), The Yoshida Dental MFG. Co., Ltd. (Japan), Midmark Corporation (U.S.), Air Techniques, Inc. (U.S.), and CEFLA s.c. (Italy).

Medical Automation Market by Application & by End-User - 2020

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry. Growing geriatric population; increasing cases of cardiovascular disease (CVD), diabetes, cancer, and orthopedic diseases; rising clinical research; and growing government expenditure on healthcare and life science research are the key factors propelling the growth of the medical automation market in the emerging countries.

On the basis of application, the medical automation market is divided into four segments, namely, diagnostic and monitoring automation (automated image analysis, automated imaging, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistic automation and trainers). The medical logistics and training segment is expected to grow at the highest rate in the next five years, owing to high adoption of these automated systems (pneumatic tubes, AGV, RTLS, and RFID) by big hospitals and diagnostic centers.

The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The therapeutic automation market segment holds the largest share in the global medical automation market. This segment is further categorized on the basis of product into non-surgical automation (defibrillators and automated medication systems) and surgical automation (surgical robots, intraoperative imaging, surgical navigation, intelligent operating rooms, and surgical simulators). In 2015, the non-surgical automation segment held a larger share of 72.9% of the global therapeutic automation market. The increasing incidences of various chronic diseases and technological advancements in defibrillators and medication systems are the key factors contributing to the growth of this market segment.

The global medical automation market is divided into four segments on the basis of end users– hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

The global medical automation market is estimated to grow at a CAGR of 9.5% from 2015 to 2020. A number of factors such as continuous advancements in various medical automation technologies; increasing government financial support for medical automation; and growing adoption of automation in laboratory, pharmacy, and medical logistics operations are propelling the growth of the global medical automation market. However, high cost of automation and stringency of regulatory procedures leading to delayed product launches are the key factors restraining the growth of this market.

On the basis of geography, medical automation  market is classified into four regions, namely, North America (U.S. and Canada), Europe, Asia-Pacific, and the Rest of the World. In 2015, the global medical automation market is estimated to be dominated by North America. Large number of ongoing clinical trials in the U.S., high adoption rate of technologically advanced medical devices in this region, and developed healthcare reimbursement structure are contributing to the large share of the North American medical automation market. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. Factors such as growing government expenditure on healthcare research, rising number of clinical research activities owing to increasing R&D outsourcing to developing Asian countries, increasing old age population and associated diseases, availability of a large patient pool, and developing healthcare infrastructure are propelling the growth of the Asia-Pacific medical automation market.

http://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html

New product launches, product approvals, and product enhancements is the primary growth strategy adopted by major players to enhance their positions in the global medical automation market. Moreover, strategies such as partnerships, agreements, and collaborations; geographic expansions; and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.

Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), General Electric Company (U.S.), Intuitive Surgical, Inc. (U.S.), Medtronic plc (U.S.), Tecan Group Ltd. (Switzerland), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

Download PDF Brochure:  http://www.marketsandmarkets.com/pdfdownload.asp?id=848

Scope of the Report

This research report categorizes the global medical automation market into the following segments:

Global Diagnostics and Monitoring Automation Market

• Automated Imaging
  • Automated Fluoroscopy
  • Automated Radiography
  • Automated Microscopy
  • Capsule Endoscopy
• Point-of-care Testing (POCT)
• Automated Image Analysis

Global Therapeutic Automation Market

• Non-surgical Automation Market
  • Defibrillators
    • Implantable Cardioverter Defibrillators
    • Automated External (Portable) Defibrillators
    • Wearable Defibrillators
    • Automated Medication Delivery Systems
      • Implantable Drug Pumps
      • Wearable Drug Pumps
• Surgical Automation Market
  • Surgical Robots
    • da Vinci
    • CyberKnife
    • RIO
    • Renaissance
  • Intelligent Operating Rooms
  • Intraoperative Imaging
    • Intraoperative Ultrasound
    • Intraoperative CT
    • Intraoperative MRI
  • Surgical Navigation Systems
  • Surgical Simulators

Global Pharmacy and Laboratory Automation Market

• Laboratory Automation Market
  • Automated Liquid Handling
  • Microplate Readers
  • Software & Informatics
  • Standalone Robots
  • Automated Storage & Retrieval Systems (ASRS)
• Pharmacy Automation Market
  • Automated Medication Dispensing Systems
  • Automated Packaging and Labeling Systems
  • Automated Medication Compounding Systems

Global Medical Logistics & Training Automation Market

• Logistics Automation
  • Hospital Asset/Patient/Staff Tracking Systems Market
    • Radiofrequency Identification
    • Real-time Location Systems (RTLS)
  • Automated Hospital Pickup & Delivery
    • Pneumatic Tube Systems (PTS)
    • Automated Guided Vehicles (AGV)
• Trainers

Global Medical Automation Market, by End User

• Hospitals & Diagnostic Centers
• Research Laboratories & Institutes
• Pharmacies
• Home/Ambulatory Care Settings & Others

Global Medical Automation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
• Asia-Pacific
• Rest of the World